U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Amoxicillin Clavulanate – Oral products
  1. Development Resources

Amoxicillin Clavulanate – Oral products

Exceptions or additions to the recognized standards

 

Minimum Inhibitory
Concentrations
(mcg/mL)

Disk Diffusion
(zone diameter in mm)

Pathogen

S

I

R

S

I

R

Haemophilus influenzae

≤4/2

-

≥8/4

≥20

-

≤19

S = Susceptible; I = Intermediate; R = Resistant

For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Anaerobes

Back to Top